← All decks

General Surgery

Chronic Pancreatitis

Built from Maingot's Abdominal Operations

What’s inside

14 sections · 173 slides

  1. 01

    Overview

    • Scope of this presentation

    1 slide

  2. 02

    What chronic pancreatitis is

    An irreversible, fibrosing disease of the gland that makes digestive juice

    • Definition of chronic pancreatitis
    • Exocrine and endocrine function of the pancreas
    • Natural history
    • Principles of decision making
    • Autodigestion and zymogen activation
    • Acute versus chronic pancreatitis
    • Limits of the acute-chronic distinction
    • Morphological subtypes of chronic pancreatitis
    • Coexistence of subtypes

    9 slides

  3. 03

    Risk factors and the TIGAR-O framework

    Why the disease is better described by risk modifiers than by causes

    • Limits of the alcohol hypothesis
    • Risk modifiers rather than causes
    • The TIGAR-O framework
    • Categories of risk in chronic pancreatitis
    • TIGAR-O risk categories: toxic, idiopathic, genetic, autoimmune
    • TIGAR-O risk categories: recurrent acute and obstructive
    • Alcohol as a risk factor
    • Proposed mechanisms of alcohol-related injury
    • Tobacco and other toxic risk factors
    • Idiopathic chronic pancreatitis

    10 slides

  4. 04

    Genetic and autoimmune disease

    Gene faults that leave trypsin switched on, and the IgG4 form of the disease

    • Hereditary pancreatitis
    • Normal trypsin activation and control
    • How PRSS1 mutations cause disease
    • Other genes in hereditary pancreatitis
    • Cystic fibrosis and the CFTR gene
    • CFTR mutations in otherwise idiopathic disease
    • Mechanism of CFTR-associated pancreatitis
    • SPINK1 as a trypsin brake
    • Safeguards against early trypsin activation
    • Autoimmune pancreatitis: pathology
    • Autoimmune pancreatitis: immunology
    • Autoimmune pancreatitis: clinical picture
    • Autoimmune conditions associated with pancreatitis
    • Recurrent and severe acute pancreatitis
    • Obstructive risk factors
    • Pancreas divisum

    16 slides

  5. 05

    Pathophysiology and the origins of pain

    How a single severe attack can prime the gland for permanent scarring

    • Obstacles to understanding pathogenesis
    • Traditional theories of acute pancreatitis
    • The sentinel acute pancreatitis event hypothesis
    • How fibrosis becomes permanent
    • From sentinel attack to fibrosed gland
    • Ductal hypertension as a source of pain
    • Neuropathic mechanism of pain
    • Two proposed sources of pancreatic pain

    8 slides

  6. 06

    Clinical presentation

    Pain, malabsorption, late diabetes, and the complications that reach beyond the gland

    • Pattern and site of pain
    • Weight loss and malnutrition
    • Steatorrhoea and exocrine insufficiency
    • Endocrine insufficiency
    • Islet entrapment within pancreatic fibrosis
    • Features of pancreatogenic diabetes
    • Endocrine risk in non-alcoholic disease
    • Extrapancreatic presentations

    8 slides

  7. 07

    Diagnosis

    History and imaging carry the diagnosis; laboratory tests add little

    • Basis of the diagnosis
    • Laboratory findings
    • Computed tomography in chronic pancreatitis
    • Calcification and the inflammatory head mass
    • Dense calcification in the pancreatic head on CT
    • Other CT findings and their meaning
    • Pseudocyst compressing the splenic vein
    • Role of pancreatic ductography
    • Duct changes of chronic pancreatitis on ERCP
    • Magnetic resonance cholangiopancreatography
    • Dorsal duct stricture on secretin-stimulated MRCP
    • The Cambridge classification
    • Cambridge grades from main duct and side branch appearance
    • Minimal change disease
    • Endoscopic ultrasound
    • Parenchymal and ductal criteria used at endoscopic ultrasound
    • Limits of endosonographic criteria
    • Tests of exocrine function
    • Tests of endocrine function
    • Serology in suspected autoimmune pancreatitis
    • Role of genetic testing
    • Value of CFTR and SPINK1 testing

    22 slides

  8. 08

    Medical management

    Removing the trigger, replacing the enzymes, and the long climb up the analgesic ladder

    • Removing inciting agents and nutritional support
    • Pancreatic enzyme replacement
    • Enzyme therapy for pain in small-duct disease
    • Antioxidants and corticosteroids
    • Pain as the dominant clinical problem
    • Pharmacotherapy for pain
    • Adjuncts in pain management
    • Celiac plexus block
    • Outcomes of neurolytic procedures

    9 slides

  9. 09

    Endoscopic therapy

    Clearing stones and stenting strictures, and how it compares with surgery

    • Endoscopic options and patient selection
    • Limitations of endotherapy over time
    • Biliary endoprosthesis in chronic calcifying pancreatitis
    • Endoscopic stenting compared with surgery
    • Randomized comparisons of stenting and surgery for main duct dilation

    5 slides

  10. 10

    Principles of surgical management

    Who needs an operation, and how the gland's shape decides which one

    • Indications for operation
    • Categories of operation
    • Morphological patterns that drive the choice
    • Risks and expected results of pancreatic surgery
    • Matching the operation to the morphology

    5 slides

  11. 11

    Large-duct disease

    Unroofing a dilated duct along its whole length and draining it into a jejunal limb

    • Definition of large-duct disease
    • Origins of the Puestow procedure
    • Partington-Rochelle modification
    • Incision and mobilisation of the duodenum
    • Entering the lesser sac
    • Control of the gastroduodenal artery
    • Locating and opening the pancreatic duct
    • Extent of the ductotomy
    • Preparing the Roux limb
    • Constructing the pancreaticojejunostomy
    • Cross-section of a lateral pancreaticojejunostomy
    • Outcomes of lateral pancreaticojejunostomy
    • Causes of failure after lateral pancreaticojejunostomy

    13 slides

  12. 12

    Chronic pancreatitis with a dominant head mass

    The Whipple operation and the three duodenum-preserving alternatives

    • Limits of drainage alone
    • Four operations in frequent use
    • Evidence from randomized trials
    • Long-term results of trials comparing head-dominant operations
    • Practice patterns on the two continents
    • Tailoring the operation to the anatomy
    • Assessing resectability at pancreaticoduodenectomy
    • Opening and inspection
    • Mobilisation and the retropancreatic tunnel
    • Portal dissection
    • Test occlusion of the gastroduodenal artery
    • Retroperitoneal anatomy exposed at pancreaticoduodenectomy
    • Dividing the upper structures
    • Standard versus pylorus-preserving resection
    • Mobilising the proximal jejunum
    • Transecting the neck and freeing the uncinate
    • Reconstruction: the pancreatic anastomosis
    • Duct-to-mucosa sutures placed over a stent
    • Constructed and completed pancreaticojejunostomy
    • Reconstruction: biliary and gastric anastomoses
    • Gastrojejunostomy and closure
    • Rationale for duodenum-preserving head resection
    • Beger procedure: exposure and division of the neck
    • Beger procedure: coring out the head
    • Anatomy after removal of the pancreatic head
    • Beger procedure: reconstruction
    • Reconstruction after a Beger procedure
    • 3.3%
    • Interpreting the Beger series
    • Randomized trial of head resection versus Whipple
    • Long-term results of that comparison
    • Limitation of the Beger operation
    • Rationale for the Frey operation
    • Frey procedure: technique
    • Frey procedure: drainage of body and tail
    • Pancreas after coring of the head in a Frey procedure
    • Pancreaticojejunostomy in the Frey procedure
    • Frey procedure compared with the Beger procedure
    • Frey procedure compared with pylorus-preserving Whipple
    • The Berne modification
    • Evidence for the Berne modification

    41 slides

  13. 13

    Small-duct disease and diffuse sclerosis

    When there is no duct to drain and no mass to remove

    • Small-duct disease and diffuse sclerosis
    • Options in small-duct disease
    • Total pancreatectomy: sequence of the operation
    • Islet isolation from the resected pancreas
    • Details of the isolation process
    • Routes for islet infusion
    • Outcomes of islet autotransplantation
    • Caveats around islet autotransplantation
    • Concerns about the transplanted islets in the liver
    • Hereditary pancreatitis with PRSS1 mutation on CT
    • Indications for total pancreatectomy with islet autotransplantation
    • The Izbicki V-shaped resection

    12 slides

  14. 14

    Summary

    What is settled, what is not, and where these patients are best treated

    • Summary of the disease
    • Summary of risk and morphology
    • Summary of treatment
    • Points to carry away
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    14 slides